Metrics
Publication
66
Open Access
2
UN Sustainable Development Goals
Education
2021 - Present
2021 - PresentPost Doctorate of Medicine
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences , Turkey
2016 - 2020
2016 - 2020Expertise In Medicine
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences , Turkey
2009 - 2015
2009 - 2015Undergraduate
Istanbul University, Istanbul Medical Faculty, Turkey
Dissertations
2019
2019Expertise In Medicine
Tek taraflı atrofik böbrekli hastaların klinik ve laboratuvar özellikleri, renal sağkalımı etkileyen faktörler
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences
Research Areas
Medicine
Academic Positions
2021 - Present
2021 - PresentResearch Assistant PhD
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences
2016 - 2020
2016 - 2020Research Assistant PhD
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences
Articles
All (30)
SCI-E, SSCI, AHCI (23)
SCI-E, SSCI, AHCI, ESCI (24)
ESCI (1)
Scopus (25)
TRDizin (6)
Other Publications (4)
2025
20251. A prospective study on the role of non-invasive tests in the evaluation of diabetes mellitus associated steatotic liver disease
İstemihan Z., Bektaş F., Bardak A. E., Kızıltaş C., Kemeç G., İmanov Z., et al.
Scientific Reports
, vol.15, no.1, 2025 (SCI-Expanded)
2025
20252. Real World Efficacy and Safety of Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Liver Transplant Recipients
Bektas E., Yilmaz A., Kikili C. I., Nuriyev K., Istemihan Z., Senkal I. V., et al.
Transplant Infectious Disease
, vol.27, no.5, 2025 (SCI-Expanded)
2025
20253. USTEKINUMAB EFFECTIVENESS AND SUSTAINABILITY IN ULCERATIVE COLITIS AND CROHN’S DISEASE
İstemihan Z., Teberik Kama E., Altın S., İmanov Z., Şenkal İ. V., Nurıyev K., et al.
Journal of İstanbul Faculty of Medicine , no.88, pp.256-263, 2025 (Peer-Reviewed Journal)
2025
20254. The role of GALAD score in the surveillance of hepatocellular carcinoma.
İstemihan Z., Şenkal İ. V., Karaca D., Nurıyev K., Rustamzade A., Genç Uluçeçen S., et al.
Scientific reports
, vol.15, no.1, pp.22279, 2025 (SCI-Expanded)
2025
20255. Anxiety and Depression Outcomes in Liver Transplant Candidates and Recipients Using the Hospital Anxiety and Depression Scale
Bardak A. E., Cifcibasi Ormeci A., Yildiz Z., Senkal V., Imanov Z., Istemihan Z., et al.
Transplantation Proceedings
, vol.57, no.6, pp.1170-1175, 2025 (SCI-Expanded)
2025
20256. The Role of Pancreatic Enzyme Insufficiency in the Etiology of Functional Dyspepsia Resistant to Standard Treatment
kemik f., CEYLAN G., Aydın A. F., Çavuş B., Ormeci A., Imanov Z., et al.
Turkish Journal of Gastroenterology
, vol.36, no.7, pp.467-473, 2025 (SCI-Expanded)
2025
20257. Results in chronic hepatitis B patients using tenofovir and entecavir for at least 10 years; HBV clearance rare, disease outcomes good: An observational cohort study
Istemihan Z., Kemeç G., Cebeci T., Çetin O., Uluçeçen S. G., Rüstemzade A., et al.
Medicine (United States)
, vol.104, no.23, 2025 (SCI-Expanded)
2025
20258. The Role of MicroRNA-192-5p in the Pathogenesis of Crohn's Disease
Dicle E. O., Ulucecen S. G., İSTEMİHAN Z., ÇAVUŞ B., OĞUZ F., KAYMAKOĞLU S., et al.
HLA
, vol.105, 2025 (SCI-Expanded)
2025
20259. Hepatopulmonary Syndrome
İstemihan Z., Kaymakoğlu S.
Türkiye Klinikleri Gastroenterohepatoloji Dergisi , vol.18, pp.47-52, 2025 (Peer-Reviewed Journal)
2025
202510. Virological and Biochemical Effects of Tenofovir Alafenamide in Different Patient Groups With Chronic Hepatitis B Virus Infection in Real-World Cohort
Bektas E., Yilmaz A., Kikili C. I., Nuriyev K., Istemihan Z., Senkal I. V., et al.
International Journal of Hepatology
, vol.2025, no.1, 2025 (ESCI)
2025
202511. Prognostic factors for long-term outcomes of unilateral atrophic kidneys in adult patients: a single-center retrospective cohort study
İstemihan Z., Dirim A. B., Uçar A. R., Bağriaçik C., Kemeç G., Mirioğlu Ş., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.55, no.3, 2025 (SCI-Expanded)
2025
202512. What are the predictors of malignancy in inflammatory bowel disease?
İstemihan Z., Çavuş B., Bardak A. E., Kirkoğlu A. M., Kiziltaş C., Silay R., et al.
Turkish Journal of Medical Sciences
, vol.55, no.4, pp.846-854, 2025 (SCI-Expanded)
2024
202413. Aceruloplasminemia as a rare hereditary disease: four case reports in a single center
İstemihan Z., İmanov Z., Çavuş B., Çifcibaşı Örmeci A., Akyüz F., Beşışık S. F., et al.
Baylor University Medical Center Proceedings , no.0, pp.1-4, 2024 (Scopus)
2024
202414. What has changed in Inflammatory Bowel Disease during last three decades?
ALTIN S., KEMEÇ G., KAYIKÇI K., DENİZ D., ÇELİK A. O., İSTEMİHAN Z., et al.
JOURNAL OF CROHNS & COLITIS
, 2024 (SCI-Expanded)
2023
202315. Diagnosis and Treatment of Autoimmune Hepatitis: Questions, Answers, and Illustrative Cases: Endorsed by Autoimmune Liver Diseases Special Interest Group, Turkish Association for the Study of Liver.
Özaslan E., Günşar F., Çiftçibaşı Örmeci A., Hatemi İ., Efe C., Akyol G., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, vol.34, no.Suppl2, 2023 (SCI-Expanded)
2023
202316. Kalp Transplantasyonunda Güncel Gastroenterolojik İzlem ve Yaklaşımlar
İstemihan Z., Çavuş B., Akyüz F.
Türkiye Klinikleri Kalp Damar Cerrahisi Dergisi , no.1, pp.167-170, 2023 (Peer-Reviewed Journal)
2023
202317. The liver worsens in non-alcoholic fatty liver disease patients as diabetes mellitus worsens and lasts longer
İSTEMİHAN Z., Bektaş F., BARDAK A. E., KIZILTAŞ C., KEMEÇ G., Imanov Z., et al.
JOURNAL OF HEPATOLOGY
, 2023 (SCI-Expanded)
2023
202318. Demographic, clinical and laboratory characteristics of adult-onset minimal change disease in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group
Aydin Z., Yilmaz M., Sipahioglu M., DERVİŞOĞLU E., Aydemir N., Uzun S., et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY
, vol.55, no.4, pp.975-982, 2023 (SCI-Expanded)
2023
202319. Efficacy and Safety of Sofosbuvir and Ledipasvir for Hepatitis C in Kidney Transplant Recipients: A Single-center Retrospective Observational Study
Artan A. S., Mirioğlu Ş., İstemihan Z., Aksoy E., Dirim A. B., Çavuş B., et al.
BALKAN MEDICAL JOURNAL
, vol.40, no.3, pp.182-187, 2023 (SCI-Expanded)
2022
202220. Different Faces of Eosinophilic Infiltration of Gastrointestinal System
İSTEMİHAN Z., ÇAVUŞ B., BERKER N., Nuriyev K., Şenkal V., İmanov Z., et al.
Journal of Enterocolitis , vol.1, no.3, pp.68-71, 2022 (Peer-Reviewed Journal)
2022
202221. What is the effect of subepithelial lesions of the esophagus on esophageal motility?
Oermeci A., Cavus B., Akas R., Istemihan Z., Imanov Z., Senkal V., et al.
European review for medical and pharmacological sciences
, vol.26, no.17, pp.6300-6309, 2022 (SCI-Expanded)
2022
202222. Is anterior segment OCT superior to slit-lamp biomicroscopic examination for Kayser Flesicher ring in Wilson's disease?
Ormeci A., Bayraktar S., Isik A. O., Cavus B., Akas R., Istemihan Z., et al.
European review for medical and pharmacological sciences
, vol.26, no.14, pp.5178-5185, 2022 (SCI-Expanded)
2022
202223. Are Hepatobiliary Manifestations Related to the Site of Involvement in Inflammatory Bowel Disease?
İstemihan Z., Çifcibaşı Örmeci A., Çavuş B., Şenkal İ. V., İmanov Z., Nuriyev K., et al.
Journal of Enterocolitis , vol.1, pp.12-16, 2022 (Peer-Reviewed Journal)
2022
202224. Optimal testosterone level to improve symptoms of hypogonadism without causing dopa-testotoxicosis in male macroprolactinoma
Caklili O. T., Ok A. M., Istemihan Z., Selcukbiricik Ö., Yarman S.
ANNALES D ENDOCRINOLOGIE
, vol.83, no.1, pp.9-15, 2022 (SCI-Expanded)
2021
202125. The relationship between glomerular IgG staining and poor prognostic findings in patients with IgA nephropathy: the data from TSN-GOLD working group
TURGUTALP K., Cebeci E., Turkmen A., DERİCİ Ü., SEYAHİ N., EREN N., et al.
BMC NEPHROLOGY
, vol.22, no.1, 2021 (SCI-Expanded)
2021
202126. Characteristics of primary glomerular diseases patients with hematuria in Turkey: the data from TSN-GOLD Working Group.
Sumnu A., TÜRKMEN K., Cebeci E., Turkmen A., EREN N., Seyahi N., et al.
International urology and nephrology
, vol.53, no.5, pp.945-954, 2021 (SCI-Expanded)
2019
201927. Co-Deposition of IgM and C3 May Indicate Unfavorable Renal Outcomes in Adult Patients with Primary Focal Segmental Glomerulosclerosis
Mirioglu Ş., Caliskan Y. K., Ozluk Y., Dirim A. B., Istemihan Z., AKYILDIZ A., et al.
KIDNEY & BLOOD PRESSURE RESEARCH
, no.5, pp.961-972, 2019 (SCI-Expanded)
2019
201928. ; The Role of the Local Bone Marrow Renin-Angiotensin System in Multiple Myeloma
Sakai B., Sayitoglu M., Istemihan Z., Karan M. A., Erten N., Dogan O., et al.
TURKISH JOURNAL OF HEMATOLOGY
, vol.36, no.3, pp.178-185, 2019 (SCI-Expanded)
2017
201729. C3 DEPOSITION MAY IMPLICATE DISEASE PROGRESSION IN PATIENTS WITH PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS
Mirioglu Ş., Dirim A. B., Istemihan Z., Akyildiz A., Ucar A., Ozluk Y., et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION
, vol.32, 2017 (SCI-Expanded)
2017
201730. GENOTYPING FOR PERSONALIZED MEDICINE IN ADULT PATIENTS WITH PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS
Mirioglu Ş., Istemihan Z., Ucar A., Dirim A. B., Akgul S., Caliskan Y.
NEPHROLOGY DIALYSIS TRANSPLANTATION
, vol.32, 2017 (SCI-Expanded)
Papers Presented at Peer-Reviewed Scientific Conferences
2025
20251. Duodenal T cell Profling in Patients with Primary Antibody Deficincies: Associations with Enteropathy
DEMİR S., KAHVECİ N., YEĞİT O. O., Yaglı M., İstemihan Z., Cavus B., et al.
EAACI, 2025, İSKOÇYA, 13 June 2025, (Summary Text)
2025
20252. The Role of MicroRNA-192-5p in the Pathogenesis of Crohn's Disease
Orhan Dicle E., Genç Uluçeçen S., İstemihan Z., Çavuş B., Oğuz F., Kaymakoğlu S., et al.
38th uropean Federation for Immunogenetics Congress, Praha, Czech Republic, 14 - 17 May 2025, vol.105, pp.84, (Summary Text)
2025
20253. Over the years, diagnostic problems in cirrhosis continue, but its etiology changes: chronic viral hepatitis is decreasing, steatotic liver disease is increasing
İSTEMİHAN Z., Celik A. O., TAŞ A., DENİZ D., MURATOĞLU Ç., NURIYEV K., et al.
European-Association-for-the-Study-of-the-Liver Congress, Amsterdam, Netherlands, 7 - 10 May 2025, vol.82, (Summary Text)
2024
20244. 10-year results under tenofovir disoproxil fumarate and entecavir in chronic hepatitis B; HBV clearance rare, disease outcomes good
İstemihan Z., Kemeç G., Cebeci T., Çetin O., Genç Uluçeçen S., Rüstemzade A., et al.
EASL Congress 2024, Milan, Italy, 5 - 08 June 2024, pp.803, (Summary Text)
2024
20245. Steatotic liver disease in diabetic patients: more serious diabetes mellitus, more serious liver disease
İSTEMİHAN Z., BEKTAŞ F., BARDAK A. E., KIZILTAŞ C., KEMEÇ G., NURİYEV K., et al.
EASL 2024, Milan, Italy, 5 - 08 June 2024, (Summary Text)
2024
20246. Steatotic liver disease in diabetic patients: more serious diabetes mellitus, more serious liver disease
İstemihan Z., Bektaş F., Bardak A. E., Kızıltaş C., Kemeç G., Nurıyev K., et al.
EASL Congress 2024, Milan, Italy, 5 - 08 June 2024, pp.551, (Summary Text)
2024
20247. The relationship between spleen stiffness and portal hypertension liver transplant patients
Nurıyev K., İstemihan Z., Telli P., Qurbanov A., Yağlı M. A., Dağcı G., et al.
EASL Congress 2024, Milan, Italy, 5 - 08 June 2024, pp.377-378, (Summary Text)
2024
20248. Clinical characteristics of patients with hereditary hemorrhagic telangiectasia: Real-life data, single-center experience
İstemihan Z., Bardak A. E., Nurıyev K., Rüstemzade A., Genç Uluçeçen S., Çavuş B., et al.
ESGE Days 2024, Berlin, Germany, 25 - 27 April 2024, pp.297, (Summary Text)
2023
20239. ARE THERE NEW PRACTICAL MARKERS TO PREDICT MALIGNANCY IN PANCREATIC CYST FLUIDS?
Anıl K. U., Çavuş B., Çifcibaşı Örmeci A., İmanov Z., Şenkal İ. V., Nurıyev K., et al.
Digestive Disease Week 2023, Washington, United States Of America, 6 - 09 May 2023, pp.774, (Summary Text)
2023
202310. WHAT ARE THE PREDICTORS OF SPLEEN STIFFNESS MEASUREMENT FAILURE BY TRANSIENT ELASTOGRAPHY?
Agargun B. F., Senkal V. I., Rustamzade A., Nuriyev K., Istemihan Z., Imanov Z., et al.
Digestive Disease Week (DDW), Illinois, United States Of America, 6 - 09 May 2023, (Summary Text)
2022
202211. Real-world data of tenofovir alafenamide in treatment-naive and experienced patients with Chronic Hepatitis B: more efficacy, less side effects
Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.
39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 22 - 27 November 2022, pp.1159-1162, (Summary Text)
2022
202212. REAL-WORLD DATA OF TENOFOVIR ALAFENAMIDE IN TREATMENT-NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: MORE EFFICACY, LESS SIDE EFFECTS
Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.
AASLD Liver Meeting , District Of Columbia, United States Of America, 4 - 08 November 2022, vol.76, pp.299, (Summary Text)
2022
202213. Dekompanse karaciğer sirozunda ince barsak tutulumlu diffüz büyük b hücreli lenfoma olgusu
Teberik Kama E., İstemihan Z., Çifcibaşı Örmeci A., Akyüz F., Kaymakoğlu S.
24. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 19 - 23 October 2022, pp.140, (Summary Text)
2021
202114. Girişimsel Gastroenterolojik İşlemlerde Hastaların Doktor Tercihinde Cinsiyet Önemli mi?
Kara İnci A., Zaralı S., Akyüz M., İmanov Z., Şenkal İ. V., İstemihan Z., et al.
38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 16 - 21 November 2021, pp.204, (Full Text)
2021
202115. Ön Segment Optik Koherans Tomografi (OCT), Wilson hastalığı tanısında Kayser Fleischer Halkası varlığını değerlendirmeki yeri - Ehil oftalmolog gerekliliğine son verecek mi?
Çifcibaşı Örmeci A., Bayraktar Ş., Işık A. O., İstemihan Z., Sarıdal M. K., Akas R., et al.
38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 16 - 21 November 2021, pp.218, (Summary Text)
2021
202116. Budd-Chiari Sendromu’nda Hepatoselüler Kanser ve Mortalitenin Değerlendirilmesi
İstemihan Z., Nurıyev K., Şenkal İ. V., İmanov Z., Sarıdal M. K., Akas R., et al.
38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 16 - 21 November 2021, pp.219, (Summary Text)
2021
202117. What should be the optimal testosterone level to improve the symptoms of hypogonadism in male macroprolactinomas?.
Telci Çaklılı Ö., Ok A. M., İstemihan Z., Soyluk Selçukbiricik Ö., Yarman E. S.
23 th European Congress of Endocrinology (ECE) 2021, 22 - 26 May 2021, pp.1-3, (Summary Text)
2020
202018. IS THE SEVERITY OF GLOMERULAR IGG STAINING IN PATIENT WITH IGA NEPHROPATHY USEFUL FOR PREDICTING POOR RENAL PROGNOSIS? THE DATA FROM TSN-GOLD WORKING GROUP
TURGUTALP K., Cebeci E., Turkmen A., DERİCİ Ü., SEYAHİ N., EREN N., et al.
57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 June 2020, vol.35, pp.800, (Summary Text)
2020
202019. CHARACTERISTICS OF PRIMARY GLOMERULAR DISEASE PATIENTS WITH HEMATURIA IN TURKEY: THE DATA FROM TSN-GOLD WORKING GROUP
Sumnu A., TÜRKMEN K., Cebeci E., Turkmen A., EREN N., Seyahi N., et al.
57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 June 2020, vol.35, pp.757, (Summary Text)
2020
202020. ADULT MINIMAL CHANGE DISEASE IN TURKEY: THE RESULTS OF TURKISH SOCIETY OF NEPHROLOGY GLOMERULAR DISEASES WORKING GROUP
Yilmaz M., Sipahioglu M., DERVİŞOĞLU E., Aydemir N., Uzun S., Istemihan Z., et al.
57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 June 2020, vol.35, pp.768, (Summary Text)
2019
201921. Diagnostic steps to explain the cause of severe hypercalcemia
İSTEMİHAN Z., MUTLU Ü., ALTINKAYNAK M., SARIBEYLİLER G., ÇAKMAK R., YENİDÜNYA YALIN G., et al.
EndoBridge 2019, Antalya, Turkey, 24 - 27 October 2019, (Summary Text)
2019
201922. Tek taraflı atrofik böbrekli hastaların klinik ve laboratuvar özellikleri, renal sağkalımı etkileyen faktörler
İSTEMİHAN Z., UÇAR A. R., DİRİM A. B., MİRİOĞLU Ş., OTO Ö. A., YILDIZ A., et al.
36. Ulusal Nefroloji Kongresi, Antalya, Turkey, 16 - 20 October 2019, pp.16-17, (Summary Text)
2019
201923. Ailesel fokal segmental glomerüloskerozda genetik mutasyon analizi
ÇALIŞKAN Y. K., MİRİOĞLU Ş., İSTEMİHAN Z., DEMİR E., UÇAR A. R., DİRİM A. B., et al.
36. Ulusal Nefroloji Kongresi, Antalya, Turkey, 16 - 20 October 2019, pp.14, (Summary Text)
2019
201924. Tek taraflı atrofik böbrekli hastaların klinik ve laboratuvar özellikleri, renal sağkalımı etkileyen faktörler
İSTEMİHAN Z., UÇAR A. R., DİRİM A. B., MİRİOĞLU Ş., OTO Ö. A., YILDIZ A., et al.
36. Ulusal Nefroloji Kongresi, Antalya, Turkey, 16 - 20 October 2019, pp.16-17, (Summary Text)
2019
201925. Ailesel fokal segmental glomerülosklerozda genetik mutasyon analizi
ÇALIŞKAN Y. K., MİRİOĞLU Ş., İSTEMİHAN Z., DEMİR E., UÇAR A. R., DİRİM A. B., et al.
36. Ulusal Nefroloji Kongresi, Antalya, Turkey, 16 - 20 October 2019, pp.14, (Summary Text)
2019
201926. Long-time overlooked blastic plasmacytoid dendritic cell neoplasm evolving into multiple organ involvement presentation
Istemihan Z., Ozkan S., Dogan O., Yonal-Hindilerden I., Kalayoglu-Besisik S.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text)
2018
201827. Cancer-associated thrombotic microangiopathies for refractory thrombotic thrombocytopenic purpura differential diagnosis
Feriz S. N., Istemihan Z., Dadin S. A., Marangoz N., Ozdemir A., Tukek T., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text)
2017
201728. MULTİPLE MİYELOMDA YENİ TEDAVİLER, ÇOĞUL TEDAVİ BASAMAKLARI, UZAYAN SAĞKALIM VE FIRSATÇI ENFEKSİYONLAR:OLGU SUNUMU
İSTEMİHAN Z., AHMED M. A., ERDEM S., ÖZKAN S. G., YÖNAL HİNDİLERDEN İ., GÜLLÜOĞLU M., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.196-197, (Summary Text)
2017
201729. Fokal Segmental Glomerulosklerozu olan erişkin hastalarda gen analizi
MİRİOĞLU Ş., İSTEMİHAN Z., AKYILDIZ A., UÇAR A. R., AKGÜL S., ÇALIŞKAN Y. K., et al.
34. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Antalya, Turkey, 18 - 22 October 2017, vol.26, no.3, pp.102, (Full Text)
2017
201730. Böbrek Nakli Alıcılarında Direkt Etkili Antivirallerle HCV Tedavisi
MİRİOĞLU Ş., İSTEMİHAN Z., ŞAHİN E., Aksoy E., DEMİR E., AKGÜL S., et al.
34. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Antalya, Turkey, 18 - 22 October 2017, vol.26, no.3, pp.35, (Summary Text)
2017
201731. Böbrek Nakli Alıcılarında Direkt Etkili Antivirallerle HCV Tedavisi
MİRİOĞLU Ş., İSTEMİHAN Z., ŞAHİN E., AKSOY E., DEMİR E., USTA AKGÜL S., et al.
34. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Antalya, Turkey, 18 - 22 October 2017, vol.26, pp.35, (Summary Text)
2017
201732. Genotyping for personalized medicine in adult patients with primary focal segmental glomerulosclerosis
MİRİOĞLU Ş., İSTEMİHAN Z., UÇAR A. R., DİRİM A. B., AKGÜL S., ÇALIŞKAN Y. K.
54th ERA-EDTA Congress, Madrid, Spain, 3 - 06 June 2017, vol.32, pp.507, (Full Text)
2017
201733. C3 deposition may implicate disease progression in patients with primary focal segmental glomerulosclerosis
MİRİOĞLU Ş., DİRİM A. B., İSTEMİHAN Z., Akyıldız A., UÇAR A. R., ÖZLÜK M. Y., et al.
54th ERA-EDTA Congress, Madrid, Spain, 3 - 06 June 2017, vol.32, pp.140-141, (Full Text)
2017
201734. GENOTYPING FOR PERSONALIZED MEDICINE IN ADULT PATIENTS WITH PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS
MİRİOĞLU Ş., İSTEMİHAN Z., UÇAR A. R., DİRİM A. B., AKGÜL S., ÇALIŞKAN Y. K.
54th ERA-EDTA Congress, Madrid, Spain, 3 - 06 June 2017, vol.32, pp.507, (Summary Text)
2017
201735. C3 DEPOSITION MAY IMPLICATE DISEASE PROGRESSION IN PATIENTS WITH PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS
MİRİOĞLU Ş., DİRİM A. B., İSTEMİHAN Z., AKYILDIZ A., UÇAR A. R., ÖZLÜK M. Y., et al.
54th ERA-EDTA Congress, Madrid, Spain, 3 - 06 June 2017, vol.32, pp.140-141, (Summary Text)
2016
201636. TİROZİN KİNAZ İNHİBİTÖRÜ (TKI) DİRENCİ VEYA İLAÇ KULLANIMINA UYUM SORUNU: KRONİK FAZ KML İMATİNİB ALTINDA APSELEŞMEYE İLERLEYEN DALAK İNFAKTI; OLGU SUNUMU
ŞENKAL N., ERDEM S., ÖZTÜRK C. K., İSTEMİHAN Z., KALAYOĞLU BEŞIŞIK S.
3. Hematolojik Onkoloji Kongresi, 21 - 24 September 2016, pp.67-69, (Summary Text)